Alcohol use among women of childbearing age is prevalent in the United States, with approximately 1 in 5 nonpregnant women reporting binge drinking (5 or more drinks on any one occasion) and 1 in 25 pregnant women reporting binge drinking. Alcohol use during pregnancy results in a spectrum of adverse outcomes known as fetal alcohol spectrum disorders. Fetal alcohol syndrome (FAS) is one of these disorders. Fetal alcohol syndrome is characterized by specific facial abnormalities and significant impairments in neurodevelopment and physical growth. Early identification of children with FAS has been shown to enhance their longterm outcomes. In an effort to improve clinical recognition of children with this condition, Centers for Disease Control and Prevention (CDC) was directed by Congress in 2002 to lead the development of uniform diagnostic criteria for FAS and other prenatal alcohol-related conditions. The purpose of this commentary is to provide clinicians a summary of the report released by CDC describing the current diagnostic criteria for FAS. In addition, advancements have been made in screening and brief interventions for alcohol use disorders in women who have the potential to make significant strides in the prevention of FAS spectrum disorders. Knowledge of the diagnostic criteria for FAS can lead to increased identification of the syndrome in infants and children and the provision of appropriate medical and support services. Screening for and intervening with women at risk for an alcohol-exposed pregnancy can prevent FAS and other fetal alcohol spectrum disorders.
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RECOGNITION OF FETAL ALCOHOL SYNDROME
The defining characteristics outlined in the expert report released by CDC include those summarized in the box "Brief Outline of Diagnostic Criteria for Fetal Alcohol Syndrome." The full report describing the scientific evidence supporting the selection of the characteristics and accompanying measurements that constitute the clinical thresholds for diagnosis can be found at http://www.cdc.gov/ ncbddd/fas/documents/fas_guide-lines_accessible.pdf.
Evidence supports the need for early recognition of FAS to reduce the secondary conditions that often accompany maturation. They include school failure, difficulties with peers, conduct problems, and mental health disorders. 5 Recognition of FAS is made difficult in the newborn period because the pattern of facial dysmorphia characterizing the condition can be subtle, and the associated central nervous system deficits might not be clearly manifested. However, under-recognition of FAS has been reported in infants born to women known to have abused alcohol during pregnancy when the findings of physician examiners familiar with the condition were compared with the findings of the infants' primary physicians. Reasons cited for under-recognition of FAS in infants include inadequate knowledge of the mother's prenatal drinking patterns and the examining physicians' lack of comfort and experience with the disorder. 6 Prevalence rates can vary greatly depending on the methods used for case identification, the geographic area, and the racial and ethnic characteristics of the population. For example, one CDC study reported prevalence rates ranging from 0.3 to 1.5 per 1,000 live births in the states of Arizona, Colorado, New York, and Alaska, with highest rates occurring in American Indian and Alaskan Natives and African Americans. 7 Another report combining studies using a variety of methodologies reported a prevalence rate of 0.5-2.0 cases per 1,000 live births. 8 Some practitioners rarely encounter a case of FAS. Knowledge of the most salient clinical characteristics of the condition may trigger recognition, particularly in cases where prenatal alcohol exposure is confirmed or suspected. to this phenomenon, it is certainly an important one. Approximately 8% of women of childbearing age are at risk of pregnancy, and half of them are actively trying to become pregnant. However, half of all pregnancies are unplanned and many women will not know they are pregnant during the early weeks of gestation and will continue consuming alcohol at levels that result in the birth of a child with fetal alcohol spectrum disorders. Therefore, identifying women who are at high risk for an alcoholexposed pregnancy and intervening with them before conception is an essential strategy for preventing alcohol-exposed pregnancies. Recently released evidence-based recommendations from the Agency for Healthcare Research Quality 11 cited screening and brief interventions as the standard of care for intervening in alcohol abuse problems in adults and extended the recommendation to pregnant women as well.
SCREENING AND INTERVENING WITH WOMEN AT RISK FOR AN ALCOHOL-EXPOSED PREGNANCY
Screening instruments have been developed and validated for 
BRIEF OUTLINE OF DIAGNOSTIC CRITERIA FOR FETAL ALCOHOL SYNDROME

Growth Problems
I. Confirmed prenatal or postnatal height or weight, or both, at or below the 10th percentile, documented at any one point in time (adjusted for age, sex, gestational age, and race or ethnicity). use in pregnant women and nonpregnant women. For pregnant women, the T-ACE (4 items that take less than a minute to administer; see box "T-ACE") and the TWEAK (5 items similar to those in the T-ACE; see box "TWEAK") are brief screening instruments that can improve identification of women with alcohol misuse problems in clinical settings better than can clinician questioning alone. 3 The TWEAK and T-ACE have been found to also be useful in screening nonpregnant populations of women. The same is true of the AUDIT, a 10-item screener that has a shorter 3-item version, the AUDIT-C. A fuller discussion of all these instruments and populations they have been tested with can be found in the report, Fetal Alcohol Syndrome: Guidelines for Referral and Diagnosis, and by logging on to http:// www.niaaa.nih.gov/publications/ Assesing%20Alcohol/index.htm.
Central Nervous System Abnormalities
INTERVENING WITH WOMEN AT RISK FOR AN ALCOHOL-EXPOSED PREGNANCY
Given that there is no established safe level of alcohol use for pregnant women, official guidelines have been issued by ACOG and AAP, 12 the Office of the Surgeon General, and the Department of Health and Human Services, 13 advising women who are pregnant or who might become pregnant to abstain from alcohol use. For adult women in general, the Dietary Guidelines for Americans 13 recommend consuming no more than 1 drink per day. However, as cited earlier, many American women engage in binge drinking and increase their risks for a host of problems, including an alcohol-exposed pregnancy. Until recently, a binge episode was defined as 5 or more 
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To score the test, a 7-point scale is used. The tolerance question scores 2 points if a woman can report she can "hold" more than 5 drinks without passing out, and a positive response to the worry question scores 2 points. Each of the last 3 questions scores 1 point for positive responses. A total of 3 or more points indicates the woman is likely to be a heavy or problem drinker. 
T-ACE Tolerance
"How many drinks does it take to make you feel high?" drinks on any one occasion for both men and women. In 2004, owing to the accumulated evidence of the more severe impact on women than on men, at lower rates of consumption and over shorter periods of time, National Institute on Alcohol Abuse and Alcoholism revised the definition of binge drinking for women to 4 or more drinks per occasion. 14 Recommendations for clinicians regarding assessment of thresholds published by the National Institute on Alcohol Abuse and Alcoholism recommend that any woman who reports drinking more than 7 drinks per week or more than 3 drinks on any given day be further assessed for risk of developing alcohol-related problems. 15 Numerous studies have documented the efficacy of brief interventions in reducing harmful alcohol use. 3 When applying these to women at risk for an alcohol-exposed pregnancy, clinical advice and counseling should include feedback regarding the risk posed, discussion of readiness to change, and assistance provided to women in developing strategies and goals for reducing hazardous use of alcohol. Primary outcomes reported among women of childbearing age receiving brief interventions in primary care settings include a 20 -25% reduction in alcohol drinks per week and episodes of binge drinking. 16 Preconceptional women may benefit from discussions that include pregnancy postponement and effective contraception to avoid an alcoholexposed pregnancy while she attempts to reach goals of alcohol reduction or abstinence. Follow-up should be conducted for every highrisk woman, and any woman who is unable to achieve her drinking goals should receive stepped-up care, including referral to formal treatment programs or community groups that provide support to women seeking to reduce hazardous alcohol use patterns. For women who are already pregnant, recent randomized studies report significant reductions in alcohol use after a brief intervention, 17 In closing, FAS and all other conditions subsumed under the umbrella of fetal alcohol spectrum disorders are entirely preventable as long as a pregnancy is an alcohol-free pregnancy. Useful screening tools are available, and brief advice and counseling are effective interventions for reducing women's risk for an alcohol-exposed pregnancy. Clinicians are encouraged to incorporate alcohol screening into their routine assessment procedures for women of childbearing age (pregnant and nonpregnant) and to provide advice and counseling appropriate to the screening results. Centers for Disease Control and Prevention and ACOG have recently joined forces to develop and disseminate pocket-sized clinical provider materials that address screening and brief intervention for women of childbearing age who are at risk for an alcohol-exposed pregnancy. Consistently, clinicians say it is important to provide them with health education materials containing messages that are clear and brief and do not require the user to navigate algorithms and text. In addition, final analyses of CDC's Project CHOICES, a brief intervention for preconceptional women at high risk for an alcoholexposed pregnancy, is currently underway with intervention content and study results expected out in 2005. Further information on all aspects discussed in this commentary are available at the following Web sites: http://www.cdc.gov/ncbddd/ fas, http://www.niaaa.nih.gov, and http://www.fascenter.samhsa.gov.
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